Columnist Dagmar Munn encourages "zebras" to show their stripes in February as part of Rare Disease Month and Rare Disease ...

A triple combination therapy identified using newly developed cell models is showing promise for treating sporadic ALS, per a study.

Columnist Kristin Neva describes the adjustments she and her husband, Todd, have made to ensure he's comfortable in his new power chair.

ALS Canada and Brain Canada have awarded $515,000 to four early-career researchers to advance ALS research and clinical care ...

The advocacy group I AM ALS secured $313 million in federal funding for its campaign to accelerate research and expand access ...

ALS Association yearly report cards show no U.S. state earned the highest score for policies supporting patients; several had ...

ALS ONE will join the ALS Network to expand ALS research efforts, improve patient services, and strengthen nationwide ...

A study is exploring why athletes, first responders, and other high performers face an increased risk of developing ALS.

An inflammatory sugar molecule produced by certain gut bacteria may play a key role in driving ALS, a study found.

In carrying on her late husband's tradition of feeding wildlife, columnist Juliet Taylor realizes that her actions are a way of honoring him.

Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.

A dream in the night takes columnist Kristin Neva back to when she and her husband, Todd, were free from ALS hanging over their heads.